Navigation Links
Michael Munter Named to Wisconsin Assisted Living Association Board
Date:7/28/2009

Chief Operating Officer for CRL Senior Living Communities to work with Association on quality initiatives

Neenah, Wis. (Vocus) July 28, 2009 -- CRL Senior Living Communities announced today that Michael Munter, the company's Chief Operating Officer has been named to the board of directors for the Wisconsin Assisted Living Association (WALA).

A seasoned healthcare executive, Munter has strong general management experience in finance, operations, marketing and business development. Having worked for one of the largest privately owned senior housing companies in the country, he has a passion for providing seniors with the highest level of customer service and quality clinical care. As a representative of CRL Senior Living Communities, Munter will provide input and direction into furthering the mission of WALA.

"This is an exciting opportunity for CRL Senior Living Communities. By partnering with an organization like WALA we can demonstrate and further our company's commitment to providing quality and innovative senior housing by working with successful like-minded individuals. It's truly an honor and a privilege to be part of such a dynamic and passionate organization," says Michael Munter, COO for CRL Senior Living Communities.

"Mike brings with him a wealth of experience in serving seniors and I'm very excited that he's accepted the offer of the position on our board. We look forward to his input as we go forward facing the many challenges and new opportunities that will face WALA in the years to come," says Bob Lightfoot, WALA board president.

With offices in Neenah, Wis.,
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2

Related medicine news :

1. Michael J. Fox Foundation Awards $3.8 Million To Drive Nine Industry Partnerships For Pre-Clinical Parkinsons Drug Development
2. Michael Unhjem Appointed to Board of Directors for Health Integrated
3. Pulmonx Announces New President and CEO Michael A. Baker to Lead Interventional Pulmonology Company
4. Michael Steele, Chairman of the Republican National Committee, Will Hold a Press Conference on Health Care - the Republican Alternative at 9 am on Monday July 20th in the Holeman Lounge of the National Press Club on the 13th Floor
5. PR Whiz Belinda Foster Launches Michael Jacksons Nurse, Cherilyn Lee, on World Media Campaign
6. Questions to Pharmacists Rise After Michael Jacksons Death
7. Celebrity Permanent Makeup Artist Slams Claim "Michael Jackson Didn't Want to be Black"
8. Expert Explains Why Propofol Was the Wrong -- and Possibly Fatal -- Drug for Michael Jackson
9. American Society of Anesthesiologists Releases Following Statement Related to Media Inquires Regarding Michael Jacksons Death
10. A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video
11. DEA Will Play Hardball in Investigating Michael Jacksons Doctors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Michael Munter Named to Wisconsin Assisted Living Association Board 
Michael Munter Named to Wisconsin Assisted Living Association Board
Breaking Medicine News(10 mins):Health News:Discovery Health's New Year, New You Week Brings Transformation and Inspiration to the Resolution Season 2Health News:Discovery Health's New Year, New You Week Brings Transformation and Inspiration to the Resolution Season 3Health News:Discovery Health's New Year, New You Week Brings Transformation and Inspiration to the Resolution Season 4Health News:Consumer Watchdog Releases Coercive Lobbying E-Mail to Employees of United Health Group, Calls It 'Political Harassment' of Workers 2Health News:Consumer Watchdog Releases Coercive Lobbying E-Mail to Employees of United Health Group, Calls It 'Political Harassment' of Workers 3Health News:Consumer Watchdog Releases Coercive Lobbying E-Mail to Employees of United Health Group, Calls It 'Political Harassment' of Workers 4Health News:Jefferson neurosurgeon helps draft new treatment guidelines for brain metastases 2Health News:Prize4Life and the Jackson Laboratory team up to fight ALS 2Health News:Prize4Life and the Jackson Laboratory team up to fight ALS 3Health News:New Report Examines the Role of Communications Technologies in Humanitarian Crises, 2Health News:New Report Examines the Role of Communications Technologies in Humanitarian Crises, 3Health News:New Report Examines the Role of Communications Technologies in Humanitarian Crises, 4
Other Medicine News:Health News:Mars First Confectionery Company to Launch Front-of-Pack Nutrition Labeling Globally 2Health News:Mars First Confectionery Company to Launch Front-of-Pack Nutrition Labeling Globally 3Health News:Mars First Confectionery Company to Launch Front-of-Pack Nutrition Labeling Globally 4Health News:Mars First Confectionery Company to Launch Front-of-Pack Nutrition Labeling Globally 5Health News:Sun Safety Champions Team Up With LPGA Tour Pro Paula Creamer 2Health News:Sun Safety Champions Team Up With LPGA Tour Pro Paula Creamer 3Health News:Sun Safety Champions Team Up With LPGA Tour Pro Paula Creamer 4Health News:GBH Communications, Inc. Offers Next Generation of LifeSize High Definition Video Communications and Telepresence Products 2Health News:GBH Communications, Inc. Offers Next Generation of LifeSize High Definition Video Communications and Telepresence Products 3Health News:MyHealthGate, Inc. Joins With LiveActive Chewy Granola Bars to Raise Digestive Health Awareness 2Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 2Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 3Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 4Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 5Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 6Health News:Social Security 2009 COLA Helps, But People with Disabilities Will Still Struggle, Says Allsup 7Health News:Women's Contraceptive Perceptions and Realities Don't Match Up 2Health News:Women's Contraceptive Perceptions and Realities Don't Match Up 3Health News:Women's Contraceptive Perceptions and Realities Don't Match Up 4
Breaking Medicine Technology:China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4WorldHeart Receives US Clinical Study Approval for the Levacor 28TM 29 VAD 4876 1WorldHeart Receives US Clinical Study Approval for the Levacor 28TM 29 VAD 4876 2WorldHeart Receives US Clinical Study Approval for the Levacor 28TM 29 VAD 4876 3Diabetes drug linked to increased risk of heart failure 54955 1Diabetes drug linked to increased risk of heart failure 54955 2Type 1 diabetes linked to immune response to wheat 54951 1Type 1 diabetes linked to immune response to wheat 54951 2
Other Medicine Technology:Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 2Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 3Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 4Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 6Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 7Data from Randomized Pilot Study, Real-World Use of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented in Symposium at EuroPCR 2008 2